| IV-27 Christophe Meille PKPD modeling of preclinical anti-tumor activity translates to first-in-human phase I study of MDM2 inhibitor HDM201 Thursday 15:10-16:40 |
| IV-27 Christophe Meille PKPD modeling of preclinical anti-tumor activity translates to first-in-human phase I study of MDM2 inhibitor HDM201 Thursday 15:10-16:40 |